World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02261584
Date of registration: 26/09/2014
Prospective Registration: No
Primary sponsor: Tanta University
Public title: Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism
Scientific title: Comparative Study of Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism
Date of first enrolment: August 2014
Target sample size: 40
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02261584
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Egypt
Contacts
Name:     Mohamed M Elkassas
Address: 
Telephone:
Email:
Affiliation:  Dr.
Name:     Asem A Elfert, MD
Address: 
Telephone:
Email:
Affiliation:  Tanta Faculty of Medicine, Professor
Name:     Fat-heya E Assel, MD`
Address: 
Telephone:
Email:
Affiliation:  Tanta Faculty of Medicine, Professor
Name:     Asem A Elfert, MD
Address: 
Telephone: +20-122-437-8188
Email: asem1967@yahoo.com
Affiliation: 
Name:     Asem A Elfert, MD
Address: 
Telephone: +20-122-437-8188
Email: asem1967@yahoo.com
Affiliation: 
Name:     Islam S Ismail
Address: 
Telephone:
Email:
Affiliation:  Dr.
Key inclusion & exclusion criteria

Inclusion Criteria:

- Liver Cirrhosis

- Hypersplenism

Exclusion Criteria:

- Patients with bad performance scale.

- Patients with hepatic encephalopathy and tense ascites.

- Patient with active esophageal variceal bleeding .

- Patients with hypocellular bone marrow (BM).

- Patients with renal failure.



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Hypersplenism
Intervention(s)
Device: Partial Splenic Embolization
Device: Microwave Thermal Coagulation
Primary Outcome(s)
Percentage of participants with improvement of hypersplenism after microwave thermal coagulation of the spleen compared with partial splenic embolization. [Time Frame: 6 months]
Secondary Outcome(s)
Secondary ID(s)
Microwave vs PSE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history